Table 2.
Univariate analysis |
Multivariate analysis |
|||
---|---|---|---|---|
Risk ratio (95% CI) | P | Risk ratio (95% CI) | P | |
Age ≧ 70 | 1.2 (0.98–1.62) | 0.0714 | ||
Size of tumor ≧ 3 cm | 1.1 (1.08–1.29) | 0.0487 | 1.05 (0.65–1.23) | 0.092 |
Number of tumors ≧ 2 | 1.1 (0.89–1.50) | 0.3059 | ||
RBC (/μL) < 400 | 1.1 (0.90–1.34) | 0.8605 | ||
WBC (/μL) < 3000 | 1.0 (0.78–1.36) | 0.5336 | ||
plt (/μL) < 10 | 1.0 (0.85–1.26) | 0.6889 | ||
PT (%) < 80 | 1.1 (0.87–1.31) | 0.3538 | ||
Alb (g/dl) < 3.6 | 1.4 (1.18–1.77) | 0.0004 | 1.85 (1.04–2.79) | 0.004 |
AST (U/L) ≧ 80 | 1.0 (0.83–1.27) | 0.4176 | ||
ALT (U/L) ≧ 80 | 1.0 (0.85–1.31) | 0.9092 | ||
T.Bil (mg/dl) ≧ 1.5 | 1.1 (0.86–1.39) | 0.7055 | ||
AFP (ng/ml) ≧ 50 | 1.6 (1.04–3.27) | 0.0050 | 1.03 (0.75–1.42) | 0.114 |
Abbreviations: Alb, albumin; AFP, α-fetoprotein; ALT, alanine aminotransferase; AST, aspartate amino transferase; CI, confidence interval; HCC, hepatocellular carcinoma; PT, prothrombin time; WBC, white blood cells; RBC, red blood cells; plt, platelet; T-Bil, total bilirubin.